| P50 | author | Paul Bieniasz | Q54632854 |
| | Nolwenn Jouvenet | Q56373579 |
| | Bryan R. Cullen | Q95269610 |
| | Hal P Bogerd | Q117803793 |
| | Heather L Wiegand | Q117803799 |
| P2093 | author name string | Brian P Doehle | |
| | Eric Hunter | |
| P2860 | cites work | Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies | Q21090536 |
| | An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22 | Q24292358 |
| | The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA | Q24305266 |
| | APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons | Q24307450 |
| | Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion | Q24529150 |
| | APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells | Q24536003 |
| | Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors | Q24537623 |
| | Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication | Q24563503 |
| | A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins | Q24564187 |
| | Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein | Q27860488 |
| | Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts | Q28179446 |
| | DNA deamination mediates innate immunity to retroviral infection | Q28179534 |
| | Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif | Q28187133 |
| | HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability | Q28207304 |
| | APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism | Q28237264 |
| | APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo | Q28275837 |
| | Cytidine deamination of retroviral DNA by diverse APOBEC proteins | Q28578747 |
| | The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys | Q29547689 |
| | HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation | Q29618937 |
| | The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif | Q29618938 |
| | Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. | Q29622903 |
| | Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. | Q30445599 |
| | Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases | Q33731838 |
| | Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes | Q33755180 |
| | The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein | Q33841186 |
| | Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase | Q33908716 |
| | Intrinsic immunity: a front-line defense against viral attack | Q34360874 |
| | APOBEC3 proteins inhibit human LINE-1 retrotransposition | Q34532057 |
| | Variable sensitivity to substitutions in the N-terminal heptad repeat of Mason-Pfizer monkey virus transmembrane protein | Q35105124 |
| | APOBEC3G targets specific virus species. | Q35704210 |
| | Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism | Q36685201 |
| | A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor | Q37094645 |
| | Human immunodeficiency virus type 1 matrix inhibits and confers cooperativity on gag precursor-membrane interactions. | Q39755256 |
| | The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release | Q39864067 |
| | APOBEC3G incorporation into human immunodeficiency virus type 1 particles | Q40214021 |
| | Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms. | Q40247008 |
| | APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. | Q40464899 |
| | Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor | Q40508338 |
| | M-PMV capsid transport is mediated by Env/Gag interactions at the pericentriolar recycling endosome | Q40637604 |
| | Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors | Q42589642 |
| | The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G | Q44653976 |
| | Mutations within the transmembrane glycoprotein of Mason-Pfizer monkey virus: loss of SU-TM association and effects on infectivity | Q45781275 |
| | Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif. | Q53852671 |
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virion | Q1757347 |
| | Mason-Pfizer monkey virus | Q18862723 |
| P304 | page(s) | 12102-12108 | |
| P577 | publication date | 2006-10-11 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | The betaretrovirus Mason-Pfizer monkey virus selectively excludes simian APOBEC3G from virion particles | |
| P478 | volume | 80 | |